Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02360891
What this trial is testing

Study of Predictive Factors of Progression of Motor Neurone Disease

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
University Hospital, Lille 500
Not applicableStudy completedNCT05163210
What this trial is testing

Effectiveness of AOT Based on Virtual Reality in Stroke Rehabilitation.

Who this might be right for
StrokeHemiplegiaHemiparesis
Azienda Ospedaliero-Universitaria di Parma 48
Not applicableStudy completedNCT01699451
What this trial is testing

DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic Florida

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Mayo Clinic 33
Early research (Phase 1)Study completedNCT01511029
What this trial is testing

Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 68
Large-scale testing (Phase 3)Ended earlyNCT03948178
What this trial is testing

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

Who this might be right for
Amyotrophic Lateral Sclerosis
Orion Corporation, Orion Pharma 227
Not applicableStudy completedNCT03613038
What this trial is testing

A Systematic Investigation of Phonetic Complexity Effects on Articulatory Motor Performance in Progressive Dysarthria

Who this might be right for
Amyotrophic Lateral SclerosisParkinson Disease
University of Missouri-Columbia 100
Testing effectiveness (Phase 2)UnknownNCT04952155
What this trial is testing

Low Dose IL-2 in the Treatment of Immune-associated ALS Syndrome

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University Third Hospital 13
Not applicableUnknownNCT05423678
What this trial is testing

Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients

Who this might be right for
ALSAmyotrophic Lateral Sclerosis
Power Life Sciences Inc. 500
Not applicableLooking for participantsNCT04944940
What this trial is testing

Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)

Who this might be right for
Spinal and Bulbar Muscular AtrophyKennedys DiseaseMotor Neuron Disease
National Institute of Neurological Disorders and Stroke (NINDS) 70
Testing effectiveness (Phase 2)Study completedNCT01786174
What this trial is testing

Gilenya in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Massachusetts General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00140218
What this trial is testing

R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Bennett, James P., Jr., M.D., Ph.D. 30
Testing effectiveness (Phase 2)Looking for participantsNCT07023835
What this trial is testing

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Zydus Therapeutics Inc. 240
Post-approval studies (Phase 4)Study completedNCT01811355
What this trial is testing

Mexiletine for the Treatment of Muscle Cramps in ALS

Who this might be right for
Muscle Cramps in Amyotrophic Lateral Sclerosis
Bjorn Oskarsson, MD 23
Not applicableUnknownNCT05475691
What this trial is testing

Longitudinal Data Collection in Pediatric and Adult Patients With Spinal Muscular Atrophy in Latin America

Who this might be right for
Spinal Muscular Atrophy
Hospital Israelita Albert Einstein 361
Post-approval studies (Phase 4)Study completedNCT01350297
What this trial is testing

Diaphragmatic Reinnervation of Tetraplegic Patients With Respiratory Insufficiency

Who this might be right for
Tetraplegia
University Hospital, Rouen 5
Not applicableStudy completedNCT02789059
What this trial is testing

Muscle Oxygenation in Effort in Neuromuscular Diseases

Who this might be right for
Neuromuscular Diseases
University Hospital, Lille 17
Not applicableStudy completedNCT02507713
What this trial is testing

Quantitative Neuromuscular Ultrasonography in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Universidad Católica San Antonio de Murcia 60
Not applicableWithdrawnNCT00846560
What this trial is testing

Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Rambam Health Care Campus
Large-scale testing (Phase 3)Ended earlyNCT04944784
What this trial is testing

Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 489
Not applicableLooking for participantsNCT06810219
What this trial is testing

Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Cognixion 10
Next Page